Spots Global Cancer Trial Database for Impact of Sequential Chemotherapy on Young Patients Breast Cancer Treated Fertility
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Impact of Sequential Chemotherapy on Young Patients Breast Cancer Treated Fertility
Official Title: Impact of Sequential Chemotherapy on Young Patients Breast Cancer Treated Fertility
Study ID: NCT01614704
Interventions
Study Description
Brief Summary: Breast cancer affect around 52 000 women in France each year. Amongst them, 7% are less than 40 years old and 2% are in between 25 and 35 years old. Significant therapeutic advances have improved the prognostic of these patients. They will all most likely to received chemotherapy. Despite the fact that chemotherapy has many side effects, these women do question the impact of the treatment on their ability to procreate. On 06/08/04 law basis, each patient is allowed to preserve gametes or germinal tissues when medical care potentially affect fertility. Functional evaluation of ovarian reserve could help comprehend new chemotherapy protocols, provide fertility information, and help individualize fertility preservation supports. Principal objective is to ensure the absence of ovarian stimulation's side effects and assess chemotherapy effects on child carrying potential.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Oscar Lambret Center, Lille, Nord Pas De Calais, France
Contact Details
Name: Audrey MAILLIEZ, MD
Affiliation: Oscar Lambret Center
Role: STUDY_CHAIR
Name: Christine DECANTER, MD
Affiliation: CHRU Lille
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
